Search Results - "Numata, Shusuke"

Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.

Authors: Hasegawa, Naomi Yasuda, Yuka Yasui‐Furukori, Norio et al.

Source: Psychiatry & Clinical Neurosciences. Oct2023, Vol. 77 Issue 10, p559-568. 10p. 1 Diagram, 6 Charts, 2 Graphs.

Subjects: Mental health services, Psychiatrists, Mental depression, Hospital wards, Psychiatric treatment, Schizoaffective disorders

Geographic Terms: Japan

X chromosome aneuploidies and schizophrenia: association analysis and phenotypic characterization.

Authors: Kushima, Itaru Aleksic, Branko Kimura, Hiroki et al.

Source: Psychiatry & Clinical Neurosciences. Dec2022, Vol. 76 Issue 12, p667-673. 7p. 2 Charts.

Subjects: X chromosome, Comparative genomic hybridization, Schizophrenia, Phenotypes, Mood stabilizers, Neuroleptic malignant syndrome

Left DLPFC activity is associated with plasma kynurenine levels and can predict treatment response to escitalopram in major depressive disorder.

Authors: Kamishikiryo, Toshiharu Okada, Go Itai, Eri et al.

Source: Psychiatry & Clinical Neurosciences. Aug2022, Vol. 76 Issue 8, p367-376. 10p. 1 Color Photograph, 1 Diagram, 1 Chart, 3 Graphs.

Subjects: Mental depression, Hamilton Depression Inventory, Kynurenine, Escitalopram

Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.

Authors: Ogasawara, Kazuyoshi Numata, Shusuke Hasegawa, Naomi et al.

Source: Neuropsychopharmacology Reports. Jun2022, Vol. 42 Issue 2, p221-225. 5p.

Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.

Authors: Numata, Shusuke Nakataki, Masahito Hasegawa, Naomi et al.

Source: Neuropsychopharmacology Reports. Jun2021, Vol. 41 Issue 2, p199-206. 8p.

Association between serum folate levels and schizophrenia based on sex.

Authors: Tomioka, Yukiko Kinoshita, Makoto Umehara, Hidehiro et al.

Source: Psychiatry & Clinical Neurosciences. Sep2020, Vol. 74 Issue 9, p466-471. 6p. 2 Charts, 3 Graphs.

Subjects: Vitamin B6, Folic acid, Analysis of covariance, Serum, Schizophrenia

Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study

Authors: Takaesu, Yoshikazu Watanabe, Koichiro Numata, Shusuke et al.

Source: Psychiatry & Clinical Neurosciences. Oct2019, Vol. 73 Issue 10, p642-648. 7p. 4 Charts, 1 Graph.

Subjects: Mental depression, Psychiatric treatment, Psychiatry education, Psychiatrists, Schizophrenia, Psychoeducation, Adjunctive behavior

Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder.

Authors: Umehara, Hidehiro Numata, Shusuke Tajima, Atsushi et al.

Source: PLoS ONE. 6/9/2016, Vol. 11 Issue 6, p1-9. 9p.

Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder.

Authors: Iga, Jun‐ichi Watanabe, Shin‐ya Numata, Shusuke et al.

Source: Human Psychopharmacology: Clinical & Experimental. May2016, Vol. 31 Issue 3, p193-199. 7p.

Subjects: Mental depression, Serotonin transporters, Genetic polymorphisms, Promoters (Genetics), Methylation, Gene expression

No association between the COMT Val158Met polymorphism and the long-term clinical response in obsessive-compulsive disorder in the Japanese population.

Authors: Umehara, Hidehiro Numata, Shusuke Tajima, Atsushi et al.

Source: Human Psychopharmacology: Clinical & Experimental. Sep2015, Vol. 30 Issue 5, p372-376. 5p.

Subjects: Catechol-O-methyltransferase, Dopamine, Noradrenaline, Genetic polymorphism research, Obsessive-compulsive disorder, Pharmacogenomics

Microarray analysis of global gene expression in leukocytes following lithium treatment.

Authors: Watanabe, Shinya Iga, Junichi Nishi, Akira et al.

Source: Human Psychopharmacology: Clinical & Experimental. Mar2014, Vol. 29 Issue 2, p190-198. 9p.

Subjects: Therapeutic use of lithium, DNA microarrays, Gene expression microarrays, Leukocytes, Interleukin-6, Immune response

An Evaluation of Association between a Novel Hippocampal Biology Related SNP (rs7294919) and Schizophrenia.

Authors: Liu, Jiewei Numata, Shusuke Ikeda, Masashi et al.

Source: PLoS ONE. Nov2013, Vol. 8 Issue 11, p1-5. 5p.

Clinical correlates associated with cognitive dysfunction in people with schizophrenia.

Authors: Tanaka, Tsunehiko Tomotake, Masahito Ueoka, Yoshinori et al.

Source: Psychiatry & Clinical Neurosciences. Oct2012, Vol. 66 Issue 6, p491-498. 8p. 3 Charts.

Subjects: People with schizophrenia, Cognition disorders, Extrapyramidal disorders, Symptoms, Cognitive ability, Information processing, Antipsychotic agents

Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder.

Authors: Kikuchi, Kumiko Iga, Jun-ichi Tayoshi, Sumiko et al.

Source: Human Psychopharmacology: Clinical & Experimental. Jun/Jul2011, Vol. 26 Issue 4/5, p358-363. 6p.

Subjects: Therapeutic use of lithium, Vascular endothelial growth factors, Messenger RNA, Antidepressants, Bipolar disorder, Leukocytes

Brief Assessment of Cognition in Schizophrenia: Validation of the Japanese version.

Authors: KANEDA, YASUHIRO SUMIYOSHI, TOMIKI KEEFE, RICHARD et al.

Source: Psychiatry & Clinical Neurosciences. Dec2007, Vol. 61 Issue 6, p602-609. 8p. 6 Charts.

Subjects: Schizophrenia, Health outcome assessment, Japanese language, Cognitive testing, Informed consent (Medical law), Continuous performance test, Short-term memory

Interaction-Driven Dynamic Fusion for Multimodal Depression Detection: A Controlled Analysis of Gating and Cross-Attention Under Class Imbalance.

Authors: Matsumoto, Kazuyuki Kiuchi, Keita Umehara, Hidehiro et al.

Source: Brain Sciences (2076-3425). Apr2026, Vol. 16 Issue 4, p366. 21p.

A Data‐Driven Psychiatric Disorder Subtype Defined by Significant Enlarged Ventricles and Cognitive Impairment: A Replication Study.

Authors: Onitsuka, Toshiaki Yasuda, Yuka Ito, Satsuki et al.

Source: Neuropsychopharmacology Reports. Mar2026, Vol. 46 Issue 1, p1-4. 4p.

Clinical behavior toward outpatients with major depressive disorder based on guideline education for psychiatrists.

Authors: Yamagata, Hirotaka Ide, Kenta Ochi, Shinichiro et al.

Source: Psychiatry & Clinical Neurosciences Reports. Dec2025, Vol. 4 Issue 4, p1-8. 8p.

Long‐Term Impact of EGUIDE Training on Facility‐Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study.

Authors: Hasegawa, Naomi Muraoka, Hiroyuki Arai, Yusuke et al.

Source: Neuropsychopharmacology Reports. Dec2025, Vol. 45 Issue 4, p1-8. 8p.

Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical setting.

Authors: Igarashi, Shun Tsuboi, Takashi Hasegawa, Naomi et al.

Source: BMC Psychiatry. 10/9/2025, Vol. 25 Issue 1, p1-10. 10p.